EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
40 hedge funds and large institutions have $274M invested in ESSA Pharma in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.23% less ownership
Funds ownership: 70.04% → 68.8% (-1.2%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
40
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$8.35M | |
| 2 | +$7.98M | |
| 3 | +$6.56M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$6.55M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$5.61M |
Top Sellers
| 1 | -$8.55M | |
| 2 | -$3.25M | |
| 3 | -$2.66M | |
| 4 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$2.47M |
| 5 |
Renaissance Technologies
New York
|
-$346K |